McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 09 2024 - 8:00AM
Business Wire
McKesson Adds New Director; Announces
Acquisition of Compile
McKesson Corporation (NYSE: MCK) will present at the 42nd Annual
J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel
in San Francisco today at 9:45 AM PT (12:45 PM ET). Executive
leadership will provide a company overview followed by a fireside
chat.
The audio webcast will be available live at McKesson’s Investor
Relations website at investor.mckesson.com, along with the
company’s slide presentation.
McKesson’s Board of Directors Elects Kevin Ozan as New
Director
The McKesson board of directors has elected Kevin Ozan as
director and member of the Audit Committee and Finance Committee,
effective January 8, 2024. With the election of Ozan, McKesson’s
board of directors increases from 11 to 12 members, 11 of whom are
independent.
“We’re pleased to welcome Kevin to the McKesson Board,” said
Donald Knauss, McKesson’s independent board chair. “His extensive
executive leadership background in strategy and finance will be
instrumental as the company continues to deliver on its growth
initiatives, advancing health outcomes for all.”
Ozan recently retired from his role as senior executive vice
president of strategic initiatives at McDonald’s Corporation.
During his 25-year tenure with the global food service retailer,
Ozan also served as executive vice president and chief financial
officer and held multiple leadership roles overseeing financial and
investor relations teams. Prior to McDonald’s, he worked for over a
decade in Ernst & Young’s audit and mergers and acquisitions
practices.
In addition to McKesson, Ozan currently serves on the board of
Cineworld, a private company with one of the largest global cinema
businesses. Ozan holds a bachelor’s degree in accounting from the
University of Michigan and a master’s degree in business from the
Kellogg School of Management at Northwestern University.
McKesson Acquires Compile
On January 4, 2024, McKesson acquired Compile, a healthcare data
platform that aggregates and integrates data from across the US
healthcare system to characterize providers and their patient
panels. The acquisition is anticipated to provide a centralized
commercial data platform for McKesson and accelerate its
capabilities in commercializing data and providing insights to
biopharma customers.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader
dedicated to advancing health outcomes for patients everywhere. Our
teams partner with biopharma companies, care providers, pharmacies,
manufacturers, governments, and others to deliver insights,
products and services to help make quality care more accessible and
affordable. Learn more about how McKesson is impacting virtually
every aspect of healthcare at McKesson.com and read Our
Stories.
Cautionary Statements
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. Forward-looking
statements may be identified by their use of terminology such as
“believes,” “expects,” “anticipates,” “may,” “will,” “should,”
“seeks,” “approximately,” “intends,” “projects,” “plans,”
“estimates,” “targets,” or the negative of these words or other
comparable terminology. The discussion of expectations and
integration of Compile may also include forward-looking statements.
Readers should not place undue reliance on forward-looking
statements, such as financial performance forecasts, which speak
only as of the date they are first made. Except to the extent
required by law, we undertake no obligation to update or revise our
forward-looking statements. Forward-looking statements involve
risks and uncertainties that could cause actual results to differ
materially from those projected, anticipated, or implied. Although
it is not possible to predict or identify all such risks and
uncertainties, we encourage investors to read the risk factors
described in our publicly available filings with the Securities and
Exchange Commission and news releases.
These risk factors include, but are not limited to: we
experience costly and disruptive legal disputes and settlements,
including regarding our role in distributing controlled substances
such as opioids; we might experience losses not covered by
insurance or indemnification; we are subject to frequently
changing, extensive, complex, and challenging healthcare and other
laws; we from time to time record significant charges from
impairment to goodwill, intangibles, and other long-lived assets;
we might not realize expected benefits from business process
initiatives; we experience cybersecurity incidents that might
significantly compromise our technology systems or might result in
material data breaches; we may be unsuccessful in achieving our
strategic growth objectives; we might be unable to successfully
complete or integrate acquisitions or other business combinations;
our technology products or services might not conform to
specifications or perform as we intend; our contracts with
government entities involve future funding and compliance risks; we
might be harmed by changes in our relationships or contracts with
suppliers; our use of third-party data is subject to limitations
that could impede the growth of our data services business; we
might be adversely impacted by healthcare reform such as changes in
pricing and reimbursement models; we might be adversely impacted by
competition and industry consolidation; we might be adversely
impacted by changes or disruptions in product supply and have
difficulties in sourcing or selling products due to a variety of
causes; we might be adversely impacted as a result of our
distribution of generic pharmaceuticals; we might be adversely
impacted by changes in the economic environments in which we
operate; changes affecting capital and credit markets might impede
access to credit, increase borrowing costs, and disrupt banking
services for us and our customers and suppliers and might impair
the financial soundness of our customers and suppliers; we might be
adversely impacted by changes in tax legislation or challenges to
our tax positions; we might be adversely impacted by fluctuations
in foreign currency exchange rates; we might be adversely impacted
by events outside of our control, such as widespread public health
issues, natural disasters, political events and other catastrophic
events; and we may be adversely affected by global climate change
or by legal, regulatory, or market responses to such change.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240108048860/en/
Rachel Rodriguez, 469-260-0556 (Investors)
Rachel.Rodriguez@McKesson.com Media Relations
MediaRelations@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Jun 2024 to Jul 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Jul 2023 to Jul 2024